LEARNING OBJECTIVES

 

At the conclusion of this activity, participants will be able to:

 

  1. Describe predictors of progressive skin tightening in patients with early diffuse cutaneous systemic sclerosis that have been incorporated into recent clinical trial designs
  2. Describe the composite outcome measure CRISS developed for clinical trials in patients with early diffuse cutaneous systemic sclerosis
  3. Review current treatment options and recent clinical trials for the treatment of early diffuse cutaneous systemic sclerosis
Session date: 
02/08/2022 - 8:30am to 9:30am CST
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Lorinda Chung, M.D., M.S.